MADD Antikörper (Center)
-
- Target Alle MADD Antikörper anzeigen
- MADD (MAP-Kinase Activating Death Domain (MADD))
-
Bindungsspezifität
- Center
-
Reaktivität
- Human, Affe
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser MADD Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunoprecipitation (IP)
- Spezifität
- Recognizes endogenous levels of MADD protein.
- Produktmerkmale
- Rabbit polyclonal antibody to MADD
- Aufreinigung
- The antibody was purified by immunogen affinity chromatography.
- Immunogen
- KLH-conjugated synthetic peptide encompassing a sequence within the center region of human MADD.
- Top Product
- Discover our top product MADD Primärantikörper
-
-
- Applikationshinweise
- WB (1:500 - 1:1000), IP (1:10 - 1:100)
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Liquid in 0.42 % Potassium phosphate, 0.87 % Sodium chloride, pH 7.3, 30 % glycerol, and 0.01 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.
- Haltbarkeit
- 12 months
-
- Target
- MADD (MAP-Kinase Activating Death Domain (MADD))
- Andere Bezeichnung
- MADD (MADD Produkte)
- Hintergrund
- DENN, IG20, KIAA0358, MAP kinase-activating death domain protein, Differentially expressed in normal and neoplastic cells, Insulinoma glucagonoma clone 20, Rab3 GDP/GTP exchange factor
- Gen-ID
- 8567
- UniProt
- Q8WXG6
- Pathways
- Caspase Kaskade in der Apoptose
-